Number of cases meeting bloods criteria
| Pathway | Development set | Validation set | ||||
| # Cancer | # Non-cancer | Prevalence | # Cancer | # Non-cancer | Prevalence | |
| Breast | 807 | 7571 | 9.6 | 424 | 5219 | 7.5 |
| Lower Gastrointestinal | 1257 | 11 401 | 9.9 | 856 | 9361 | 8.4 |
| Upper Gastrointestinal | 662 | 5317 | 11.1 | 428 | 4337 | 9.0 |
| Gynaecological | 407 | 3098 | 11.6 | 218 | 2278 | 8.7 |
| Urological | 1836 | 4677 | 28.2 | 1143 | 3063 | 27.2 |
| Lung | 687 | 1380 | 33.2 | 177 | 616 | 22.3 |
| Haematological | 403 | 654 | 38.1 | 180 | 343 | 34.4 |
| Head and neck | 546 | 4293 | 11.3 | 346 | 3177 | 9.8 |
| Skin | 1468 | 3910 | 27.3 | 1287 | 3427 | 27.3 |
Details of the cases which meet the acceptance criteria for the analyses presented in this paper. Prevalence is calculated only for those cases meeting the criteria, and not for all patients entering a given pathway.